Stock Track | Quidel Surges 8.70% Pre-market as UBS Raises Target Price

Stock Track11-06

Shares of Quidel (QDEL), also known as QuidelOrtho Corp, soared 8.70% in pre-market trading on Thursday, following a significant target price upgrade from UBS. The investment bank raised its price target for QuidelOrtho from $26 to $31, signaling increased confidence in the company's future performance.

The substantial boost in the target price appears to have sparked investor optimism, driving the stock's pre-market rally. UBS's move suggests that the bank sees potential for growth and improved financial performance in QuidelOrtho's business, which specializes in diagnostic healthcare products.

However, it's worth noting that analyst opinions on QuidelOrtho remain mixed. Recent reports indicate that market experts are divided in their assessments of the company's prospects. This divergence in analyst views adds an element of complexity to the stock's outlook, despite the positive pre-market movement. Investors will likely be watching closely to see if the stock can maintain its momentum when regular trading begins and how it performs in the coming days as the market digests these conflicting signals.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1177450826?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-06 21:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1177450826","market":"sg","top_or_hot":-1,"title":"Stock Track | Quidel Surges 8.70% Pre-market as UBS Raises Target Price","media":"Stock Track","content":"<p>Shares of Quidel (QDEL), also known as QuidelOrtho Corp, soared 8.70% in pre-market trading on Thursday, following a significant target price upgrade from UBS. The investment bank raised its price target for QuidelOrtho from $26 to $31, signaling increased confidence in the company's future performance.</p>\n\n<p>The substantial boost in the target price appears to have sparked investor optimism, driving the stock's pre-market rally. UBS's move suggests that the bank sees potential for growth and improved financial performance in QuidelOrtho's business, which specializes in diagnostic healthcare products.</p>\n\n<p>However, it's worth noting that analyst opinions on QuidelOrtho remain mixed. Recent reports indicate that market experts are divided in their assessments of the company's prospects. This divergence in analyst views adds an element of complexity to the stock's outlook, despite the positive pre-market movement. Investors will likely be watching closely to see if the stock can maintain its momentum when regular trading begins and how it performs in the coming days as the market digests these conflicting signals.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Quidel Surges 8.70% Pre-market as UBS Raises Target Price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Quidel Surges 8.70% Pre-market as UBS Raises Target Price\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-06 21:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Quidel (QDEL), also known as QuidelOrtho Corp, soared 8.70% in pre-market trading on Thursday, following a significant target price upgrade from UBS. The investment bank raised its price target for QuidelOrtho from $26 to $31, signaling increased confidence in the company's future performance.</p>\n\n<p>The substantial boost in the target price appears to have sparked investor optimism, driving the stock's pre-market rally. UBS's move suggests that the bank sees potential for growth and improved financial performance in QuidelOrtho's business, which specializes in diagnostic healthcare products.</p>\n\n<p>However, it's worth noting that analyst opinions on QuidelOrtho remain mixed. Recent reports indicate that market experts are divided in their assessments of the company's prospects. This divergence in analyst views adds an element of complexity to the stock's outlook, despite the positive pre-market movement. Investors will likely be watching closely to see if the stock can maintain its momentum when regular trading begins and how it performs in the coming days as the market digests these conflicting signals.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"QDEL","symbol_name":"窥得儿医药","start_time":0,"source_url":"","article_id":"1177450826","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1177450826","pubTimestamp":1762434346,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Quidel (QDEL), also known as QuidelOrtho Corp, soared 8.70% in pre-market trading on Thursday, following a significant target price upgrade from UBS. The investment bank raised its price...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"QDEL":"窥得儿医药"},"translate_title":"个股追踪|瑞银上调目标价Quidel盘前大涨8.70%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"QDEL":1},"content_text":"Shares of Quidel (QDEL), also known as QuidelOrtho Corp, soared 8.70% in pre-market trading on Thursday, following a significant target price upgrade from UBS. The investment bank raised its price target for QuidelOrtho from $26 to $31, signaling increased confidence in the company's future performance.\nThe substantial boost in the target price appears to have sparked investor optimism, driving the stock's pre-market rally. UBS's move suggests that the bank sees potential for growth and improved financial performance in QuidelOrtho's business, which specializes in diagnostic healthcare products.\nHowever, it's worth noting that analyst opinions on QuidelOrtho remain mixed. Recent reports indicate that market experts are divided in their assessments of the company's prospects. This divergence in analyst views adds an element of complexity to the stock's outlook, despite the positive pre-market movement. Investors will likely be watching closely to see if the stock can maintain its momentum when regular trading begins and how it performs in the coming days as the market digests these conflicting signals.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1177450826","isCrawlerRequest":true}